---
figid: PMC7145987__fonc-10-00371-g0002
figtitle: P53 pathway dysfunction
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC7145987
filename: fonc-10-00371-g0002.jpg
figlink: pmc/articles/PMC7145987/figure/F2/
number: F2
caption: Mechanisms of p53 pathway dysfunction. The p53 pathway can be disrupted in
  cancer by mutation of the TP53 gene, overexpression of MDM2 e.g., by gene amplification
  or loss of p14ARF expression by gene methylation or deletion.
papertitle: Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma.
reftext: Harriet E. D. Southgate, et al. Front Oncol. 2020;10:371.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.909958
figid_alias: PMC7145987__F2
figtype: Figure
organisms_ner:
- Mus musculus
redirect_from: /figures/PMC7145987__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7145987__fonc-10-00371-g0002.html
  '@type': Dataset
  description: Mechanisms of p53 pathway dysfunction. The p53 pathway can be disrupted
    in cancer by mutation of the TP53 gene, overexpression of MDM2 e.g., by gene amplification
    or loss of p14ARF expression by gene methylation or deletion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Trp53
  - Mdm2
  - Rf
  - It
  - tumour
---
